​

Achilles Therapeutics (ACHL) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

ACHL Stock Forecast

Achilles Therapeutics (ACHL) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a 35.14% increase from the last price of $1.48.

High: $2 Avg: $2 Low: $2 Last Closed Price: $1.48

ACHL Stock Rating

Achilles Therapeutics stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 1 Hold (25.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 1 2 Strong Sell Sell Hold Buy Strong Buy

ACHL Price Target Upside V Benchmarks

TypeNameUpside
StockAchilles Therapeutics35.14%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.48$1.48$1.48
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 25----11
Feb, 25----11
Jan, 251---12
Dec, 24111-14
Nov, 24111--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 04, 2024Joseph CatanzaroPiper Sandler$2.00$0.90122.22%35.14%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 04, 2024Piper SandlerOverweightNeutraldowngrade
Dec 07, 2022Chardan CapitalBuyBuyhold
Dec 07, 2022Piper SandlerOverweightOverweighthold
Dec 06, 2022OppenheimerPerformdowngrade

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.75-----
Avg Forecast$-1.38$-0.18$-0.12$-1.22$-1.43$-1.68
High Forecast$-0.87$-0.03$-0.02$-1.22$-1.43$-1.68
Low Forecast$-1.65$-0.33$-0.22$-1.22$-1.43$-1.68
Surprise %26.81%-----

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-70M $-56M $-42M $-28M $-14M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-69.94M-----
Avg Forecast$-50.26M$-7.20M$-4.80M$-48.77M$-57.16M$-67.15M
High Forecast$-34.71M$-1.30M$-618.94K$-48.77M$-57.16M$-67.15M
Low Forecast$-65.81M$-13.10M$-8.97M$-48.77M$-57.16M$-67.15M
Surprise %39.14%-----

ACHL Forecast FAQ

Is Achilles Therapeutics stock a buy?

Achilles Therapeutics stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Achilles Therapeutics is a favorable investment for most analysts.

What is Achilles Therapeutics's price target?

Achilles Therapeutics's price target, set by 4 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential 35.14% change from the previous closing price of $1.48.

How does Achilles Therapeutics stock forecast compare to its benchmarks?

Achilles Therapeutics's stock forecast shows a 35.14% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Achilles Therapeutics over the past three months?

  • March 2025: 0% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 100.00% Strong Sell.
  • February 2025: 0% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 100.00% Strong Sell.
  • January 2025: 50.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 50.00% Strong Sell.

What is Achilles Therapeutics’s EPS forecast?

Achilles Therapeutics's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.18, marking a -89.71% decrease from the reported $-1.75 in 2023. Estimates for the following years are $-0.12 in 2025, $-1.22 in 2026, $-1.43 in 2027, and $-1.68 in 2028.

What is Achilles Therapeutics’s revenue forecast?

Achilles Therapeutics's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $0, followed by $0 for 2026, $0 for 2027, and $0 for 2028.

What is Achilles Therapeutics’s net income forecast?

Achilles Therapeutics's net income forecast for the fiscal year ending in December 2024 stands at $-7.195M, representing a -89.71% decrease from the reported $-69.935M in 2023. Projections indicate $-4.797M in 2025, $-48.767M in 2026, $-57.161M in 2027, and $-67.155M in 2028.